| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A024R8Z1 | Microsomal glutathione S-transferase 3, isoform CRA_a; | MGST3; | NULL | 152 | human |
| D3DVA4 | KIAA0907, isoform CRA_a; | KIAA0907; | NULL | 327 | human |
| A0A068C1W5 | Cytochrome c oxidase subunit I; | COX1; | NULL | 513 | human |
| J7H4F6 | NANOG; Fragment; | NANOG; | NULL | 138 | human |
| E7E4V8 | Cytochrome c oxidase subunit 1; EC 1.9.3.1; | COX1; | NULL | 513 | human |
| C4P092 | Disrupted in schizophrenia 1 isoform 28; Disrupted in schizophrenia 1 isoform 39; Disrupted in schizophrenia 1 isoform 4; Disrupted in schizophrenia 1 protein; | DISC1; | NULL | 382 | human |
| A0A024R374 | Cathepsin B, isoform CRA_a; | CTSB; | NULL | 339 | human |
| A0A024R1I0 | Neurofibromin 2 (Bilateral acoustic neuroma), isoform CRA_g; | NF2; | NULL | 548 | human |
| A0A024R6E9 | HCG1814221, isoform CRA_a; | NULL | NULL | 90 | human |
| C9J0J7 | Profilin-2; | PFN2; | NULL | 91 | human |
| B3DE47 | ATP synthase subunit a; | ATP6; atp6; | NULL | 226 | human |
| Q4GSG2 | ATP synthase subunit a; | ATPase; 6; atp6; | NULL | 226 | human |
| A0A024QZ41 | Transmembrane protein 97, isoform CRA_a; | TMEM97; | NULL | 194 | human |
| Q76EI7 | Apolipoprotein A-II; | APOA2; | NULL | 27 | human |
| Q9NTH0 | HCG1791715; Putative uncharacterized protein DKFZp434I0714; Fragment; | DKFZp434I0714; | NULL | 136 | human |
| D3DVN5 | Transmembrane protein 175; Uncharacterized protein; | MGC4618; TMEM175; | NP_001284352.1;NP_001284353.1;NP_001284354.1;XP_005272360.1; | 422 | human |
| J3QLF3 | Developmentally-regulated GTP-binding protein 2; | DRG2; | NULL | 90 | human |
| A0A024R0L6 | Platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit 29kDa, isoform CRA_a; | PAFAH1B3; | NULL | 231 | human |
| A0A024RCT9 | High mobility group AT-hook 1, isoform CRA_b; | HMGA1; | NULL | 328 | human |
| Q6N037 | Putative uncharacterized protein DKFZp686A11192; RNA-binding region (RNP1, RRM) containing 2, isoform CRA_d; | DKFZp686A11192; RNPC2; | NULL | 367 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |